Connect With Us
Subscribe Now
Log In
Home
News
Education
Health
Tech
STEM
Advanced Manufacturing & Logistics
Life Sciences
Ag INnovation
INPower
Videos
Big Wigs
Submit Big Wigs
Events
Innovate Southwest Indiana â Evansville
Innovate West Central Indiana – Terre Haute
Innovate East Central – Muncie
Innovate Northeast Indiana – Fort Wayne
Newsletters
Podcasts
On-Air
TV & Radio Listings
Content Studio
Sponsored Content
Contact
About IIB
Meet the Team
Contact Us
Advertise
Gift Cards
Flagship Stations
Gerry’s Message
Speaking Engagement Request
Search
GO
Connect With Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
COMPASS Pathways Plc - American Depository Shares
(NQ:
CMPS
)
7.020
+0.120 (+1.74%)
Streaming Delayed Price
Updated: 10:07 AM EST, Jan 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about COMPASS Pathways Plc - American Depository Shares
< Previous
1
2
3
4
5
6
7
8
9
...
30
31
Next >
Washington State Bills Seek to Legalize Psychedelics for Therapeutic Use
February 24, 2025
Via
Investor Brand Network
Compass Pathways to announce fourth quarter and year-end financial results on February 27th, 2025
February 18, 2025
From
Compass Pathways plc
Via
Business Wire
Mind Medicine Getting An 'RFK Bump'? Retail Gets More Bullish As Stock Heads For Best Day In Over 10 Months
↗
February 14, 2025
Kennedy has previously advocated for decriminalizing psychedelics for therapeutic use, citing his son’s positive experience with the hallucinogenic brew ayahuasca.
Via
Stocktwits
RFK Jr. Confirmation Looms. How Kennedy Could 'Go Wild' On Health Care.
↗
February 12, 2025
The Senate will vote Thursday on whether to put RFK Jr. in charge of health. It's unclear how he will impact biotech stocks.
Via
Investor's Business Daily
Uncovering Potential: Compass Pathways's Earnings Preview
↗
October 30, 2024
Via
Benzinga
Compass Pathways to Participate in Oppenheimer 35th Annual Healthcare Life Sciences Conference
February 05, 2025
From
Compass Pathways plc
Via
Business Wire
Compass Pathways Appoints Steve Levine, M.D., as Chief Patient Officer
January 21, 2025
From
Compass Pathways plc
Via
Business Wire
Compass Pathways Announces Pricing of Underwritten Offering
January 10, 2025
From
Compass Pathways plc
Via
Business Wire
Compass Pathways to Be Added to the NASDAQ Biotechnology Index (NBI)
December 18, 2024
From
Compass Pathways plc
Via
Business Wire
Is Your Mind Ready to Consider Investing in Psychedelics Stocks?
↗
November 29, 2024
Don't jump in without doing some research first.
Via
The Motley Fool
Compass Pathways to Participate in December Investor Conferences
November 25, 2024
From
Compass Pathways plc
Via
Business Wire
COMPASS Pathways: Institutional Pressure Amid $43M Market Cap Decline, What's Next For This Psychedelics Co?
↗
November 25, 2024
COMPASS Pathways faces $43M market cap loss, raising concerns among institutional investors holding 30% ownership.
Via
Benzinga
Despegar.com, Zai Lab, Bloom Energy And Other Big Stocks Moving Higher On Friday
↗
November 15, 2024
Via
Benzinga
Pfizer, Moderna, Novavax Take A Beating After Trump Taps Kennedy To Head Up HHS
↗
November 15, 2024
President-elect Donald Trump tapped widely known vaccine skeptic Robert F. Kennedy Jr. to lead the Department of Health and Human Services.
Via
Investor's Business Daily
Topics
Government
FDA Endorses CaaMTech's Psilocin Drug Development For Depression Treatment
↗
November 14, 2024
FDA supports CaaMTech's CT-4201 psilocin program for depression, advancing psychedelic therapy and clearing key regulatory hurdles.
Via
Benzinga
AI And Psychedelics: A Marriage Made In Heaven For Mental Health Care?
↗
November 13, 2024
AI and psychedelic medicine are merging, with research showing AI's role in drug discovery, trials, and personalized mental health care.
Via
Benzinga
Topics
Artificial Intelligence
Top 3 Health Care Stocks You'll Regret Missing In November
↗
November 05, 2024
Via
Benzinga
Compass Pathways Plc (CMPS) Q3 2024 Earnings Call Transcript
↗
October 31, 2024
CMPS earnings call for the period ending September 30, 2024.
Via
The Motley Fool
Topics
Earnings
Nasdaq Down 500 Points; Uber Shares Dip After Q3 Results
↗
October 31, 2024
Via
Benzinga
As Psilocybin Trials Face Delays, Compass Pathways (CMPS) Cuts Workforce To Conserve Cash
↗
October 31, 2024
Compass Pathways delays key Phase 3 psilocybin trial readouts, triggering a 30% workforce reduction amid efforts to conserve cash and refocus.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
October 31, 2024
Via
Benzinga
Crude Oil Gains 1%; Meta Shares Fall Following Q3 Results
↗
October 31, 2024
Via
Benzinga
Estée Lauder, Robinhood, eBay And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
↗
October 31, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
October 31, 2024
Via
Benzinga
Compass Pathways Announces Third Quarter 2024 Financial Results and Business Updates
October 31, 2024
From
Compass Pathways plc
Via
Business Wire
12 Health Care Stocks Moving In Friday's After-Market Session
↗
October 25, 2024
Via
Benzinga
Compass Pathways to Announce Third Quarter Financial Results on October 31, 2024
October 24, 2024
From
Compass Pathways plc
Via
Business Wire
Could Psilocybin Be A Game-Changer For Millions Battling Depression? New Study Says Yes
↗
October 07, 2024
Over 5 million Americans with depression could be eligible for psilocybin-assisted therapy if FDA-approved, signaling vast market potential.
Via
Benzinga
Psilocybin Breakthrough: Study Reveals Potential Application For Body Dysmorphic Disorder
↗
September 26, 2024
New study suggests psilocybin may help treat body dysmorphic disorder by rewiring brain connectivity and reducing obsessive thought patterns.
Via
Benzinga
Compass Pathways to Participate in Cowen Psychedelics and Novel Mechanisms in Neuropsychiatry Summit
September 23, 2024
From
Compass Pathfinder Limited
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
...
30
31
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
